BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37884921)

  • 1. The impact of COVID-19 on the lives of Canadians with and without non-communicable chronic diseases: results from the iCARE Study.
    Deslauriers F; Gosselin-Boucher V; Léger C; Vieira AM; Bacon SL; Lavoie KL
    BMC Public Health; 2023 Oct; 23(1):2106. PubMed ID: 37884921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge of non-communicable diseases and access to healthcare services among adults before and during COVID-19 pandemic in rural Tanzania.
    Sirili N; Kilonzi M; Kiwango G; Lengai E; Nandala R; Mwakawanga DL; Philipo EG; Thobias JM; Frumence G
    Front Public Health; 2024; 12():1342885. PubMed ID: 38605870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Mental Health Impact of COVID-19 Lockdowns on Persons with Non-Communicable Diseases in Trinidad and Tobago.
    Reid SD; Motilal S; Pooransingh S; St Bernard G; Ivey MA
    Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of the COVID-19 Pandemic on Healthy Lifestyle Behaviors and Perceived Mental and Physical Health of People Living with Non-Communicable Diseases: An International Cross-Sectional Survey.
    Azzouzi S; Stratton C; Muñoz-Velasco LP; Wang K; Fourtassi M; Hong BY; Cooper R; Balikuddembe JK; Palomba A; Peterson M; Pandiyan U; Krassioukov A; Tripathi DR; Tuakli-Wosornu YA; Hajjioui A
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to healthcare services for people with non-communicable diseases during the COVID-19 pandemic in Ibadan, Nigeria: a qualitative study.
    Ojewale LY; Mukumbang FC
    BMC Health Serv Res; 2023 Nov; 23(1):1231. PubMed ID: 37946244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK.
    Daimer S; Mihatsch LL; Neufeld SAS; Murray GK; Knolle F
    Elife; 2022 Jul; 11():. PubMed ID: 35781372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Medical Digital Technologies for Noncommunicable Diseases for Follow-Up during the COVID-19 Pandemic.
    Hussein ESE; Al-Shenqiti AM; Ramadan RME
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries.
    Bullen C; McCormack J; Calder A; Parag V; Subramaniam K; Majumdar A; Huang PH; Devi R; El Bizri L; Goodyear-Smith F
    Prim Health Care Res Dev; 2021 Jun; 22():e30. PubMed ID: 34120672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian healthcare workers' mental health and health behaviours during the COVID-19 pandemic: results from nine representative samples between April 2020 and February 2022.
    Boucher VG; Haight BL; Léger C; Deslauriers F; Bacon SL; Lavoie KL; Puterman EM;
    Can J Public Health; 2023 Oct; 114(5):823-839. PubMed ID: 37548891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the impact of coronavirus disease 19 on hospitalization rates for chronic non-communicable diseases in Brazil.
    Guimarães RA; Policena GM; Paula HDSC; Pedroso CF; Pinheiro RS; Itria A; Braga Neto OO; Teixeira AM; Silva IA; Oliveira GA; Batista KA
    PLoS One; 2022; 17(3):e0265458. PubMed ID: 35324951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health Promotion and Prevention of Non-Communicable Diseases by Public Health Departments in Baden-Württemberg during the COVID-19 Pandemic: Results of an Online Survey].
    Siegel A; Hesmert D; Mangold J; Klein A; Häske D; Wössner S; Rieger MA; Joos S; Mahler C
    Gesundheitswesen; 2024 Jun; 86(6):404-411. PubMed ID: 38467149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Prediction Model for the Management of Noncommunicable Diseases Among Older Syrian Refugees Amidst the COVID-19 Pandemic in Lebanon.
    McCall SJ; El Khoury T; Salibi N; Abi Zeid B; El Haddad M; Alawieh MF; Abdulrahim S; Chaaya M; Ghattas H; Sibai AM
    JAMA Netw Open; 2022 Oct; 5(10):e2231633. PubMed ID: 36227600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-communicable diseases care during COVID-19 pandemic: A mixed-method study in Khurda district of Odisha, India.
    Sahoo KC; Kanungo S; Mahapatra P; Pati S
    Indian J Med Res; 2021 May&Jun; 153(5&6):649-657. PubMed ID: 34380806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inequalities in access to new medication delivery services among non-communicable disease patients during the COVID-19 pandemic: findings from nationally representative surveys in Thailand.
    Nontarak J; Vichitkunakorn P; Waleewong O
    Int J Equity Health; 2023 Feb; 22(1):38. PubMed ID: 36849923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring key-stakeholder perceptions on non-communicable disease care during the COVID-19 pandemic in Kenya.
    Sureshkumar S; Mwangi KJ; Gathecha G; Marcus K; Kohlbrenner B; Issom D; Benissa MR; Aebischer-Perone S; Braha N; Candela E; Chhabra KG; Desikachari BR; Dondi A; Etchebehere M; Kengne AP; Missoni E; Mustapha F; Palafox B; Pati S; Madhu PP; Peer N; Quint J; Tabrizi R; Yusoff H; Oris M; Beran DH; Balabanova D; Etter JF
    Pan Afr Med J; 2023; 44():153. PubMed ID: 37455892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying opportunities to engage communities with social mobilisation activities to tackle NCDs in El Salvador in the context of the global COVID-19 pandemic.
    Caperon L; Arakelyan S; Innocenti C; Ager A
    Int J Equity Health; 2021 Oct; 20(1):222. PubMed ID: 34627271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care for the urban poor in India during the pandemic: Uninterrupted management of non-communicable diseases and home-based care of patients with COVID-19 infection.
    Abraham S; John SM; Gupta A; Biswas S; Khare MM; Mukherjee P; Frankline AC
    Front Public Health; 2022; 10():1043597. PubMed ID: 36699918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolevel association of COVID-19 with non-communicable disease risk factors in India.
    Gaur K; Khedar RS; Mangal K; Sharma AK; Dhamija RK; Gupta R
    Diabetes Metab Syndr; 2021; 15(1):343-350. PubMed ID: 33503583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
    Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
    BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study.
    Licher S; Heshmatollah A; van der Willik KD; Stricker BHC; Ruiter R; de Roos EW; Lahousse L; Koudstaal PJ; Hofman A; Fani L; Brusselle GGO; Bos D; Arshi B; Kavousi M; Leening MJG; Ikram MK; Ikram MA
    PLoS Med; 2019 Feb; 16(2):e1002741. PubMed ID: 30716101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.